Treatment of benign breast disease with bromocriptine
暂无分享,去创建一个
[1] R. Deitch. Commentary from Westminster. Abortion (Amendment) Bill. , 1980, Lancet.
[2] T. G. Muldoon. Characterization of mouse mammary tissue estrogen receptors under conditions of differing hormonal backgrounds. , 1978, Journal of steroid biochemistry.
[3] F. Di Carlo,et al. Interference of gestagens and androgens with rat uterine oestrogen receptors. , 1978, The Journal of endocrinology.
[4] B. Andersch,et al. Treatment of premenstrual tension syndrome with bromocriptine. , 1978, Acta endocrinologica. Supplementum.
[5] W. Malarkey,et al. Disordered nocturnal prolactin regulation in women with breast cancer. , 1977, Cancer research.
[6] McManus Mj,et al. Stimulation of DNA Synthesis by Human Placental Lactogen or Insulin in Organ Cultures of Benign Human Breast Tumors , 1977 .
[7] J. Larsen,et al. EFFECT OF BROMOCRIPTINE ON THE PREMENSTRUAL SYNDROME. A DOUBLE‐BLIND CLINICAL TRIAL , 1977, British journal of obstetrics and gynaecology.
[8] B. Palmer,et al. Bromocriptine for severe mastalgia. , 1977, British medical journal.
[9] J. Djiane,et al. Prolactin–progesterone antagonism in self regulation of prolactin receptors in the mammary gland , 1977, Nature.
[10] Ward Hw. Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma. , 1977 .
[11] S. Brooks,et al. Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7). , 1977, Cancer research.
[12] A. Coppen,et al. Bromocriptine and premenstrual syndrome: controlled study. , 1977, British medical journal.
[13] C. Robyn,et al. Prolactin and human reproduction , 1977 .
[14] V. Cararach,et al. Treatment of Fibrocystic Disease of the Breast With a Prolactin Inhibitor: 2-Br-Alpha- Ergocryptine (CB-154) , 1976, Obstetrics and gynecology.
[15] L. J. Benedek-Jaszmann,et al. PREMENSTRUAL TENSION AND FUNCTIONAL INFERTILITY Aetiology and Treatment , 1976, The Lancet.
[16] H. Rochefort,et al. Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin. , 1976, Endocrinology.
[17] K. Chihara,et al. Plasma prolactin responses to thyrotropin‐releasing hormone in patients with breast cancer , 1976, Cancer.
[18] C. Robyn. [Prolactin and breast cancer]. , 1975, Pathologie-biologie.
[19] D. Pugsley,et al. POTENTIAL PITFALL IN BIOASSAY OF SERUM-GENTAMICIN , 1975, The Lancet.
[20] M. Pike,et al. Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. , 1975, The New England journal of medicine.
[21] L. Sherman,et al. Prolactin and breast carcinoma. , 1975, The New England journal of medicine.
[22] A. Barrett,et al. Prolactin-dependent breast cancer. , 1975 .
[23] V. Seagroatt,et al. Prolactin Concentrations in Patients with Breast Cancer , 1974, British medical journal.
[24] F. Cleton,et al. Plasma-prolactin in human breast cancer. , 1974, Lancet.
[25] Gordon Hiroshi Sasaki,et al. Prolactin and progesterone effect on specific estradiol binding in uterine and mammary tissues in vitro. , 1973, Biochemical and biophysical research communications.
[26] R. G. Wilson,et al. Plasma prolactin in breast cancer. , 1973, European journal of cancer.
[27] E. Pozo,et al. THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine) , 1972 .
[28] A. Segaloff. Hormones and breast cancer. , 1966, Recent progress in hormone research.